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nana presenting under the same circumstances should be regarded as a potential pathogen? My groupings are not based on isoenzyme findings alone: they are based on clinical observations, eventually matched in blind studies to isoenzyme patterns (see Sargeaunt & Williams 1979 , Sargeaunt et al. 1978 , 1980 , 1982a .
Regarding statistics, my thesis is founded on the examination to date of 1423 subjects harbouring E. histolytica. Organisms expressing zymodeme I have never been demonstrated in tissue, but have only ever been found in the gut lumen.
To assess the ability of this particular organism (zymodeme I) to invade requires a prolonged study, in all age groups and both sexes. Assuming that E. histolytica was the only species of amoeba present in the subjects studied by Dr Robertson and his colleagues, then the presence of E. histolytica zymodeme I cysts (apparently not even haematophagus trophozoites) in the subjects, coupled with mucosal reaction, does not constitute a challenge to our hypothesis on zymodeme-reiated pathogenicity. We do not, however, deny that so far unidentified host factors may play a role in pathogenesis in exceptional cases. In practically every case, pregnancy cramp arises from the presence of dilated veins in the limbs which shoot a massive amount of blood into the calf muscles when the patient ffexes or extends the foot at the ankle joint when 'stretching' in bed and thus, inadvertently, using the calf muscle pump to suck this vast amount of blood from the subcutaneous tissues into the muscles.
The treatment is simple. Instruct the patient to sleep with the foot of the bed raised 9 inches. This empties the legs of excess venous blood within 10 minutes of going to bed, and the cramp ceases from that moment and does not reappear. One of the minor virtues of this method is that, in addition to being inexpensive, it is also 100% successful.
The only contraindication is the presence of severe oesophageal reflux (heartburn) and then it is up to the patient to decide which is preferablecramp or heartburn; although, of course, the heartburn can always be mitigated by the use of an antacid. Yours faithfully STANLEY RIVLlN 10 January 1983
Calciwn metabolism during rifampicin and isoniazid therapy for tuberculosis From Dr W Perry Faculty of Medicine King Faisal University, Dammam, Saudi Arabia Dear Sir, I should like to reply to the interesting comments of Drs Brodie and Hillyard published last November (p 919). Our paper (July 1982 Journal. p 533) was mainly concerned to observe a clear clinical effect on calcium metabolism in patients receiving rifampicin and isoniazid. Only nutritionally-deficient Indians had evidence of osteomalacia during therapy, whereas Europeans showed no evidence, suggesting that any effect over an 18-month period was likely to be small Of course, a small effect may be of some importance in the Indian group, but during metabolic calcium balance the osteomalacic patients had increased intestinal calcium absorption during mid-summer. This experiment provides good evidence of normal vitamin D function during combined therapy. What it does not do is exclude a direct effect of the drugs on bone itself, for which there is little evidence at present. Brodie and his colleagues (1982) agree that the combined effect of both drugs was less than they predicted from the two drugs alone, a point which we were at some pains to emphasize, and that only the 25-hydroxycholecalciferol parameter was reduced at six months. However, their patients had also received ethambutol and thus a different pharmacokinetic situation was being observed compared to our patients on rifampicin and isoniazid alone.
The data they used from the British Thoracic Association (1981) study did show a small but
